These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P; Bathien N Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
4. Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes. Moore DC; Bowers MB Am J Psychiatry; 1980 Oct; 137(10):1202-5. PubMed ID: 6106390 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic trials in tardive dyskinesia. Villeneuve A Can Psychiatr Assoc J; 1978 Oct; 23(6):411-5. PubMed ID: 30534 [TBL] [Abstract][Full Text] [Related]
6. [Physiopathology and curative treatment of tardive dyskinesia]. Wolf MA; Gautier J Encephale; 1987; 13(5):301-8. PubMed ID: 2892663 [TBL] [Abstract][Full Text] [Related]
7. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia. Morselli PL; Fournier V; Bossi L; Musch B Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656 [TBL] [Abstract][Full Text] [Related]
10. Cholinergic treatments for tardive dyskinesia. Alphs LD; Davis JM Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629 [No Abstract] [Full Text] [Related]
11. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. Quinn N; Marsden CD J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic treatment of tardive dyskinesia: a word of caution. Kucharski LT; Unterwald EM Schizophr Bull; 1981; 7(4):571-3. PubMed ID: 6798690 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies against tardive dyskinesia. Two decades of experience. Jeste DV; Wyatt RJ Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655 [TBL] [Abstract][Full Text] [Related]
14. Current psychopathological theories of tardive dyskinesia and their implications for future research. Ananth J Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649 [TBL] [Abstract][Full Text] [Related]
18. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia. Alpert M; Friedhoff AJ; Diamond F Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444 [No Abstract] [Full Text] [Related]
19. Treatment of tardive dyskinesia. Hollister LE Curr Psychiatr Ther; 1980; 19():89-97. PubMed ID: 6109597 [No Abstract] [Full Text] [Related]